RETEPLASE Side Effects

5839947-8 | Coagulopathy, Haemorrhage Intracranial, Hemiplegia
on Aug 07, 2008 Female patient from UNITED STATES , weighting 174.2 lb, was diagnosed with myocardial infarction and was treated with Reteplase (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, haemorrhage intracranial, hemiplegia. Reteplase dosage: 10mg Once Iv.

5472260-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Liver Function Test Abnormal
Patient was taking Reteplase (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, liver function test abnormal on Sep 21, 2007 from UNITED STATES Additional patient health information: Female patient , 42 years of age, was diagnosed with deep vein thrombosis (What is deep vein thrombosis?) and. Reteplase dosage: . During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), COUMADIN (View Coumadin Review and Coumadin Label ), LOVENOX (View Lovenox Review and Lovenox Label ), VICODIN (View Vicodin Review and Vicodin Label ).

5447587-8 | Abdominal Pain, Condition Aggravated, Coronary Artery Disease, Epigastric Discomfort, Nausea
Adverse event was reported on Aug 20, 2007 by a Male patient taking Reteplase (View Usage) (Dosage: 5 Iu;bid;iv) was diagnosed with acute myocardial infarction and. Location: POLAND , 42 years of age, weighting 176.4 lb, After Reteplase was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), condition aggravated, coronary artery disease (What is coronary artery disease?), epigastric discomfort, nausea (What is nausea?). During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (10 Mg;x1;iv; 39.6 Mg;x1;iv) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CILAZAPRIL (View Cilazapril Review and Cilazapril Label ), TICLOPIDINE HCL (View Ticlopidine Hcl Review and Ticlopidine Hcl Label ), ACARD (View Acard Review and Acard Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

5357299-7 | Cardiac Failure, Coronary Artery Disease, Myocardial Ischaemia
on May 31, 2007 Male patient from UNITED STATES , 48 years of age, weighting 158.7 lb, was diagnosed with acute myocardial infarction and was treated with Reteplase (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, coronary artery disease (What is coronary artery disease?), myocardial ischaemia. Reteplase dosage: 5 Iu; Bid; Iv. During the same period patient was treated with ABCIXIMAB (ABCIXIMAB) (See Image) (View Abciximab (abciximab) Review and Abciximab (abciximab) Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.


5339873-7 | Injection Site Irritation, Injection Site Pain
on May 14, 2007 Male patient from UNITED STATES , 60 years of age, was diagnosed with acute myocardial infarction and was treated with Reteplase (View Usage). Patient had the following side effects: injection site irritation, injection site pain. Reteplase dosage: Iv. Patient was hospitalized.

5294070-9 | Infusion Related Reaction, Pain
Patient was taking Reteplase (View Usage). After Reteplase was administered, patient had the following side effects: infusion related reaction, pain (What is pain?) on Mar 22, 2007 from UNITED STATES Additional patient health information: Male patient , 68 years of age, was diagnosed with acute myocardial infarction and. Reteplase dosage: Iv. Patient was hospitalized.

5294069-2 | Infusion Related Reaction, Pain
Adverse event was reported on Mar 22, 2007 by a Male patient taking Reteplase (View Usage) (Dosage: Iv) was diagnosed with acute myocardial infarction and. Location: UNITED STATES , 63 years of age, Patient experienced the following unwanted or unexpected effects: infusion related reaction, pain (What is pain?). Patient was hospitalized.

5294067-9 | Infusion Related Reaction, Pain
on Mar 22, 2007 Male patient from UNITED STATES , 72 years of age, was diagnosed with acute myocardial infarction and was treated with Reteplase (View Usage). Patient had the following side effects: infusion related reaction, pain (What is pain?). Reteplase dosage: Iv. Patient was hospitalized.

5257256-5 | Brain Oedema
on Feb 16, 2007 Female patient from UNITED STATES , 83 years of age, was diagnosed with cerebrovascular accident and was treated with Reteplase (View Usage). After Reteplase was administered, patient had the following side effects: brain oedema. Reteplase dosage: Iart. During the same period patient was treated with ABCIXIMAB (See Image) (View Abciximab Review and Abciximab Label ).

5257071-2 | Brain Herniation, Brain Oedema
Patient was taking Reteplase (View Usage). Patient experienced the following unwanted or unexpected effects: brain herniation, brain oedema on Feb 16, 2007 from UNITED STATES Additional patient health information: Male patient , 38 years of age, was diagnosed with cerebrovascular accident and. Reteplase dosage: Iart. During the same period patient was treated with ABCIXIMAB (.25 Mg/kg; Iv; .125 Ug/kg; Iv) (View Abciximab Review and Abciximab Label ).

5242162-2 | Brain Oedema
Adverse event was reported on Jan 30, 2007 by a Female patient taking Reteplase (View Usage) (Dosage: Iart) was diagnosed with cerebrovascular accident and. Location: UNITED STATES , 83 years of age, Patient had the following side effects: brain oedema. During the same period patient was treated with ABCIXIMAB (See Image) (View Abciximab Review and Abciximab Label ).

5242161-0 | Brain Herniation, Brain Oedema, Ischaemic Stroke, Neurological Symptom
on Jan 30, 2007 Male patient from UNITED STATES , 38 years of age, was diagnosed with cerebrovascular accident and was treated with Reteplase (View Usage). After Reteplase was administered, patient had the following side effects: brain herniation, brain oedema, ischaemic stroke, neurological symptom. Reteplase dosage: Iart. During the same period patient was treated with ABCIXIMAB (See Image) (View Abciximab Review and Abciximab Label ).

5202458-7 | Pulmonary Oedema
on Oct 28, 2005 Male patient from UNITED STATES , 66 years of age, weighting 121.3 lb, was diagnosed with acute myocardial infarction and was treated with Reteplase (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary oedema. Reteplase dosage: X1; Iv. During the same period patient was treated with ABCIXIMAB (See Image) (View Abciximab Review and Abciximab Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), BETA BLOCKING AGENTS (View Beta Blocking Agents Review and Beta Blocking Agents Label ), ACE INHIBITOR NOS (View Ace Inhibitor Nos Review and Ace Inhibitor Nos Label ), CHOLESTEROL AND TRIGLYCERINE REDUCERS (View Cholesterol-and Triglycerine Reducers Review and Cholesterol-and Triglycerine Reducers Label ), DIURETICS (View Diuretics Review and Diuretics Label ), ANTIARRHYTHMICS, CLASS I AND III (View Antiarrhythmics, Class I And Iii Review and Antiarrhythmics, Class I And Iii Label ).

5132015-2 | Thrombocytopenia
Patient was taking Reteplase (View Usage). Patient had the following side effects: thrombocytopenia on Oct 10, 2006 from ITALY Additional patient health information: Male patient , 57 years of age, weighting 172.0 lb, was diagnosed with acute myocardial infarction and. Reteplase dosage: 5 Iu; X2; Iv. During the same period patient was treated with ABCIXIMAB (ABACIXIMAB) (See Image) (View Abciximab (abaciximab) Review and Abciximab (abaciximab) Label ), HEPARIN (View Heparin Review and Heparin Label ). Patient was hospitalized.

5122507-4 | Coronary Artery Stenosis, Ejection Fraction Decreased
Adverse event was reported on Sep 20, 2006 by a Male patient taking Reteplase (View Usage) (Dosage: See Image) was diagnosed with acute myocardial infarction and. Location: ITALY , 72 years of age, weighting 220.5 lb, After Reteplase was administered, patient had the following side effects: coronary artery stenosis, ejection fraction decreased. During the same period patient was treated with REOPRO (See Image) (View Reopro Review and Reopro Label ), HEPARIN (View Heparin Review and Heparin Label ), ACE INHIBITOR (View Ace Inhibitor Review and Ace Inhibitor Label ). Patient was hospitalized.

5122506-2 | Aortic Calcification, Coronary Artery Stenosis, Ejection Fraction Decreased, Intracardiac Thrombus
on Sep 20, 2006 Male patient from POLAND , 52 years of age, weighting 180.8 lb, was diagnosed with acute myocardial infarction and was treated with Reteplase (View Usage). Patient experienced the following unwanted or unexpected effects: aortic calcification, coronary artery stenosis, ejection fraction decreased, intracardiac thrombus. Reteplase dosage: Iv. During the same period patient was treated with REOPRO (Iv) (View Reopro Review and Reopro Label ), TICLOPIDINE (View Ticlopidine Review and Ticlopidine Label ), RANITIDINE (View Ranitidine Review and Ranitidine Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), NITROGLYCERIN (View Nitroglycerin Review and Nitroglycerin Label ). Patient was hospitalized.

5122505-0 | Coronary Artery Stenosis, Haematocrit Decreased, Haemoglobin Decreased, Red Blood Cell Count Decreased
on Sep 20, 2006 Male patient from POLAND , 73 years of age, weighting 176.4 lb, was diagnosed with acute myocardial infarction and was treated with Reteplase (View Usage). Patient had the following side effects: coronary artery stenosis, haematocrit decreased, haemoglobin decreased, red blood cell count decreased. Reteplase dosage: Iv. During the same period patient was treated with REOPRO (Iv) (View Reopro Review and Reopro Label ), TICLOPIDINE (View Ticlopidine Review and Ticlopidine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), TRIMETAZIDINE (View Trimetazidine Review and Trimetazidine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ). Patient was hospitalized.

4996107-0 | Coronary Artery Disease, Coronary Artery Stenosis, Myocardial Ischaemia, Post Procedural Complication
Patient was taking Reteplase (View Usage). After Reteplase was administered, patient had the following side effects: coronary artery disease (What is coronary artery disease?), coronary artery stenosis, myocardial ischaemia, post procedural complication on Apr 25, 2006 from NETHERLANDS Additional patient health information: Male patient , 46 years of age, weighting 220.5 lb, was diagnosed with acute myocardial infarction and. Reteplase dosage: Iv. During the same period patient was treated with REOPRO (Iv) (View Reopro Review and Reopro Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

4668410-5 | Dialysis, Eosinophilia, Fat Embolism, Fluid Overload, Gastric Ulcer, Hypotension, Renal Atrophy, Renal Failure Acute
Adverse event was reported on May 12, 2005 by a Female patient taking Reteplase (View Usage) (Dosage: ) . Location: , 68 years of age, Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), eosinophilia, fat embolism, fluid overload, gastric ulcer, hypotension, renal atrophy, renal failure acute. During the same period patient was treated with HEPARIN (View Heparin Review and Heparin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.